Former 100m world record holder Asafa Powell, who tested positive for the banned stimulant oxilofrine last June, has told the Jamaica Anti-Doping Commission that he did not inform anti-doping officials about most of the supplements he was taking because the products were new and he couldn't remember their names.
Powell said he was unaware of the World Anti-Doping Agency rules during the hearing into his failed drug test.
The 31-year-old sprinter testified on Tuesday before a disciplinary panel.
Over two days of hearings, at least, Powell and his attorneys will try to explain why he tested positive for the banned stimulant oxilofrone, Sport24 reports.
Powell's former teammate, Sherone Simpson, also tested positive for the same stimulant at the sprinting powerhouse's national trials in June.
Powell, Simpson and their agent have blamed a newly-hired trainer who provided the sprinters with supplements.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
